Home/ Stocks/ VOR

Vor Biopharma Inc. Common Stock

VOR XNAS

$16.94 +0.65 (+4.07%) ▲ 15-min delayed

Open

$15.98

High

$17.32

Low

$15.91

Volume

1.17M

Market Cap

$917.91M

About Vor Biopharma Inc. Common Stock

Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 76 Website →

Key Financials

Period	Revenue	Net Income	EPS
TTM 2025	$0	$-695,981,000	$-70.50
FY 2025	$0	$-695,981,000	$-70.50
Q3 2025	$0	$-812,684,000	$-121.63
Q2 2025	$0	$-1,573,669,000	$-12.56

Related Market News

No specific coverage for VOR yet. Check out our latest market news or earnings calendar.

Get VOR Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Vor Biopharma Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.